The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes
MN Zairis, EN Adamopoulou, SJ Manousakis, AG Lyras… - Atherosclerosis, 2007 - Elsevier
We evaluated whether high circulating levels of serum amyloid A (SAA), fibrinogen,
interleukin-6 (IL-6) or leukocytes count (LC), can provide any additional predictive value …
interleukin-6 (IL-6) or leukocytes count (LC), can provide any additional predictive value …
The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients …
SG Foussas, MN Zairis, SS Makrygiannis… - Heart, 2007 - heart.bmj.com
Objectives: To evaluate, using continuous 12-lead ECG ST-segment monitoring, the role of
circulating levels of both cardiac troponin I (cTnI) and high-sensitivity C reactive protein (hs …
circulating levels of both cardiac troponin I (cTnI) and high-sensitivity C reactive protein (hs …
[PDF][PDF] The significance of circulating levels of both
EN Adamopoulou, CD Olympios, SK Argyrakis… - Heart, 2007 - zairis.eu
Objectives: To evaluate, using continuous 12-lead ECG ST-segment monitoring, the role of
circulating levels of both cardiac troponin I (cTnI) and high-sensitivity C reactive protein (hs …
circulating levels of both cardiac troponin I (cTnI) and high-sensitivity C reactive protein (hs …
[CITATION][C] Biomarkers of Inflammation and Outcome in Acute Coronary Syndromes (BIAS) Investigators. The impact of hs C-reactive protein and other inflammatory …
MN Zairis, EN Adamopoulou, SJ Manousakis, AG Lyras… - Atherosclerosis, 2007